Search results
Showing results for
The RDM Researcher Association is run by researchers for researchers. Our goal is to create a supportive and inclusive community. Our activities range from organising career development and networking events to hosting social gatherings that connect researchers from different RDM divisions.
New pump-priming awards support cross-cutting research across RDM
22 July 2026
Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.
Professor Leanne Hodson receives Physiological Society Prize Lecture
21 July 2026
The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.
New RDM course builds capacity in hyperpolarised MRI
20 July 2026
Researchers, students and imaging specialists from across the UK and Europe recently completed a new training programme in hyperpolarised MRI at Oxford. This course builds expertise in a rapidly developing imaging technology with applications across healthcare and biomedical research.
First real-world trial shows AI could reduce need for contrast injections in heart MRI scans
15 July 2026
The technology could make advanced heart MRI faster, cheaper and more accessible.
Professor Rajesh Thakker receives prestigious William F. Neuman Award
13 July 2026
Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.
Beyond cancer dependency maps: the PRECISE vision
10 July 2026
Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.
MRC WIMM achieves Gold Green Impact award
3 July 2026
Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.
New personalised therapy targets chronic blood cancer
2 July 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Professor Jan Rehwinkel receives funding to tackle viral threats
25 June 2026
A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Professor KJ Patel awarded major European Research Council Advanced Grant
23 June 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
AI tool reveals hidden organ damage caused by high blood pressure
22 June 2026
Researchers at the University of Oxford have developed an artificial intelligence (AI) tool that may help doctors better understand how high blood pressure damages different organs in different people - potentially paving the way for more personalised treatment in future.
New studies shed light on how best to guide heart artery procedures
19 June 2026
Three clinical trials have shed new light on which approaches are most useful when treating narrowed heart arteries. They challenge the current guidance on how to insert stents.
Study reveals blood stem cells can ‘remember’ inflammation
27 May 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.